FrancophonIA/ELRC3.0 huggingface dataset:
English: Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Slovenian: Binocrit 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,5 ml raztopine za injiciranje.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 6,000 IU/0.6 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Binocrit 6.000 i.e./0,6 ml injekcija epoetin alfa i.v./s.c.
English: Binocrit 10,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/410/015
Slovenian: Binocrit 10.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/410/015
English: Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Slovenian: Binocrit 40.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 1 ml raztopine za injiciranje.
English: Binocrit is indicated for the treatment of symptomatic anaemia (haemoglobin concentration of ≤ 10 g/dL) in adults with low- or intermediate-1-risk primary myelodysplastic syndromes (MDS) who have low serum erythropoietin (< 200 mU/mL).
Slovenian: ≤ 10 g/dl) pri odraslih s primarnimi mielodisplastičnimi sindromi (MDS) z nizkim ali srednjim-1
English: Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe
Slovenian: Binocrit 40.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 5,000 IU/0.5 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Binocrit 5.000 i.e./0,5 ml injekcija epoetin alfa i.v./s.c.
English: Binocrit 10,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Slovenian: Binocrit 10.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 10.000 i.e. epoetina alfa*, kar ustreza 84,0 mikrogramov na ml. 1 ml napolnjena injekcijska brizga vsebuje 10.000 mednarodnih enot (i.e.), kar ustreza 84,0 mikrogramov epoetina alfa.
English: Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe
Slovenian: Binocrit 2.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe
Slovenian: Binocrit 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Slovenian: Binocrit 2.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 1 ml raztopine za injiciranje.
English: Binocrit 10,000 IU/1 mL solution for injection in a pre-filled syringe
Slovenian: Binocrit 10.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/410/001
Slovenian: Binocrit 1.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/410/001
English: Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per mL
Slovenian: Binocrit 1.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 2.000 i.e. epoetina alfa*, kar ustreza 16,8 mikrogramov na ml. 0,5 ml napolnjena injekcijska brizga vsebuje 1.000 mednarodnih enot (i.e.), kar ustreza 8,4 mikrogramov epoetina alfa.
English: Binocrit 10,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Slovenian: Binocrit 10.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 1 ml raztopine za injiciranje.
English: Side effects from an overdose of Binocrit are unlikely.
Slovenian: Ni verjetno, da bi se pojavili neželeni učinki zaradi prevelikega odmerka zdravila
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 40,000 IU/1 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Binocrit 40.000 i.e./1 ml injekcija epoetin alfa i.v./s.c.
English: Skin and subcutaneous tissue disorders
Slovenian: Bolezni kože in podkožja izpuščaj pogosti urtikarija3
English: Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Slovenian: Binocrit 4.000 i.e./0,4 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 10.000 i.e. epoetina alfa*, kar ustreza 84,0 mikrogramov na ml. 0,4 ml napolnjena injekcijska brizga vsebuje 4.000 mednarodnih enot (i.e.), kar ustreza 33,6 mikrogramov epoetina alfa.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 3,000 IU/0.3 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Binocrit 3.000 i.e./0,3 ml injekcija epoetin alfa i.v./s.c.
English: Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Slovenian: Binocrit 8.000 i.e./0,8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 10.000 i.e. epoetina alfa*, kar ustreza 84,0 mikrogramov na ml. 0,8 ml napolnjena injekcijska brizga vsebuje 8.000 mednarodnih enot (i.e.), kar ustreza 67,2 mikrogramov epoetina alfa.
English: Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Slovenian: Binocrit 9.000 i.e./0,9 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 10.000 i.e. epoetina alfa*, kar ustreza 84,0 mikrogramov na ml. 0,9 ml napolnjena injekcijska brizga vsebuje 9.000 mednarodnih enot (i.e.), kar ustreza 75,6 mikrogramov epoetina alfa.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 20,000 IU/0.5 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Binocrit 20.000 i.e./0,5 ml injekcija epoetin alfa i.v./s.c.
English: Binocrit is used to treat anaemia in adults with a bone marrow disorder that causes a severe disruption in the creation of blood cells (myelodysplastic syndromes).
Slovenian: Zdravilo Binocrit se uporablja za zdravljenje anemije pri odraslih z boleznijo kostnega mozga,
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 10,000 IU/1 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Binocrit 10.000 i.e./1 ml injekcija epoetin alfa i.v./s.c.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 2,000 IU/1 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Binocrit 2.000 i.e./1 ml injekcija epoetin alfa i.v./s.c.
English: Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Slovenian: Binocrit 6.000 i.e./0,6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 10.000 i.e. epoetina alfa*, kar ustreza 84,0 mikrogramov na ml. 0,6 ml napolnjena injekcijska brizga vsebuje 6.000 mednarodnih enot (i.e.), kar ustreza 50,4 mikrogramov epoetina alfa.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 1,000 IU/0.5 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Binocrit 1.000 i.e./0,5 ml injekcija epoetin alfa i.v./s.c.
English: Placebo
Slovenian: subkutano.
English: Talk to your doctor, pharmacist or nurse before using Binocrit.
Slovenian: Pred začetkom uporabe zdravila Binocrit se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
English: In paediatric patients with chronic renal failure where intravenous access is routinely available (haemodialysis patients) administration of Binocrit by the intravenous route is preferable.
Slovenian: Pri pediatričnih bolnikih s kronično ledvično odpovedjo, kjer je rutinsko na voljo intravenski dostop
English: Binocrit 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Slovenian: Binocrit 3.000 i.e./0,3 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 10.000 i.e. epoetina alfa*, kar ustreza 84,0 mikrogramov na ml. 0,3 ml napolnjena injekcijska brizga vsebuje 3.000 mednarodnih enot (i.e.), kar ustreza 25,2 mikrogramov epoetina alfa.
English: Common side effects These may affect up to 1 in 10 people.
Slovenian: Pojavijo se lahko pri največ 1 od 10 bolnikov
English: Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Slovenian: Binocrit 1.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,5 ml raztopine za injiciranje.Pakiranja po 1 ali 6 brizg.
English: Binocrit should be administered to patients with anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)).
Slovenian: Bolnikom z anemijo (npr. s koncentracijo hemoglobina ≤ 10 g/dl (6,2 mmol/l)) je treba zdravilo
English: Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Slovenian: Binocrit 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 40.000 i.e. epoetina alfa*, kar ustreza 336,0 mikrogramov na ml. 0,5 ml napolnjena injekcijska brizga vsebuje 20.000 mednarodnih enot (i.e.), kar ustreza 168,0 mikrogramov epoetina alfa.
English: 1 vial
Slovenian: Velikost pakiranja viala (steklo) 1 viala viala (steklo) 2 viali viala (steklo) 5 vial
English: It can be used in adults or children over the age of 6 years.
Slovenian: Uporablja se lahko pri odraslih ali otrocih, starejših od 6 let.
English: EMA/HMPC/322933/2013
Slovenian: EMA/HMPC/322933/2013 Odbor za zdravila rastlinskega izvora (HMPC)
English: It should be taken during the day at least half an hour to one hour before or after taking other medicines and not immediately before bed-time.
Slovenian: Jemati ga je treba čez dan, vsaj pol ure do eno uro pred ali po jemanju drugih zdravil, in ne neposredno pred spanjem.
English: The effectiveness of psyllium seed in softening stools is based on its laxative effects and no specific data are available.
Slovenian: Učinkovitost semena indijskega trpotca pri mehčanju blata temelji na njegovem odvajalnem učinku, posebnih podatkov pa ni na voljo.
English: This summary is not intended to provide practical advice on how to use medicines containing psyllium seed.
Slovenian: Povzetek ni namenjen zagotavljanju praktičnih nasvetov o uporabi zdravil, ki vsebujejo seme indijskega trpotca.
English: There is a risk of a build-up of hard, dry stool, particularly if psyllium seed is swallowed without enough liquid.
Slovenian: Obstaja tveganje za kopičenje trdega, suhega blata, zlasti kadar se seme indijskega trpotca ne zaužije z dovolj tekočine.
English: How does psyllium seed work as a medicine?
Slovenian: Kako seme indijskega trpotca deluje kot zdravilo?
English: This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of psyllium seed.
Slovenian: To je povzetek znanstvenih zaključkov Odbora za zdravila rastlinskega izvora (HMPC) v zvezi z medicinsko uporabo semena indijskega trpotca.
English: Further information on the risks associated with psyllium seed medicines, including the appropriate precautions for their safe use, can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Slovenian: Dodatne informacije o tveganjih, povezanih z zdravili, ki vsebujejo seme indijskega trpotca, vključno z ustreznimi previdnostmi ukrepi za njihovo varno uporabo, so na voljo v monografiji na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: Psyllium seed is the common name for the seed of the plant Plantago afra L. or Plantago indica L. The plant is cultivated or gathered to obtain the seeds for medicinal use.
Slovenian: Seme indijskega trpotca je splošno ime za seme rastlin Plantago afra L. et Plantago indica L. Rastlini se gojita ali nabirata za pridobivanje semen za medicinsko uporabo.
English: The HMPC conclusions on the use of psyllium seed medicines for treating habitual constipation and to soften stools are based on their ‘well-established use'.
Slovenian: Zaključki odbora HMPC o uporabi zdravil, ki vsebujejo seme indijskega trpotca in se uporabljajo za zdravljenje stalnega zaprtja in omehčanje blata, temeljilo na „dobro uveljavljeni uporabi“.
English: Psyllium seed should be taken with plenty of liquid.
Slovenian: Seme indijskega trpotca je treba zaužiti z veliko tekočine.
English: What is psyllium seed?
Slovenian: Kaj je seme indijskega trpotca?
English: Psyllium seed is used in the form of ripe, whole, dry seeds or as preparations made by powdering the seeds.
Slovenian: Seme indijskega trpotca se uporablja v obliki celih, zrelih, posušenih semen ali v obliki pripravkov, izdelanih z drobljenjem semen v prašek.
English: The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing psyllium seed.
Slovenian: Ugotovitve odbora HMPC države članice EU upoštevajo pri ocenjevanju vlog za izdajo dovoljenja za promet z zdravili rastlinskega izvora, ki vsebujejo seme indijskega trpotca.
English: Information on the use and licensing of psyllium seed medicines in EU Member States should be obtained from the relevant national authorities.
Slovenian: Za informacije o uporabi in dovoljenjih za promet z zdravili, ki vsebujejo seme indijskega trpotca, v državah članicah EU se obrnite na pristojni nacionalni organ.
English: Any applications for the licensing of medicines containing psyllium seeds have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC.
Slovenian: Vlogo za izdajo dovoljenja za promet z zdravili, ki vsebujejo semena indijskega trpotca, je treba predložiti pristojnemu nacionalnemu organu za zdravila, ki bo to vlogo za izdajo dovoljenja za promet z zdravilom rastlinskega izvora ocenil in upošteval znanstvene zaključke odbora HMPC.
English: Further information on the HMPC assessment of psyllium seed medicines, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Slovenian: Dodatne informacije o oceni zdravil, ki vsebujejo seme indijskega trpotca, ki jo je opravil odbor HMPC, vključno z njegovimi znanstvenimi zaključki, so na voljo na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: The HMPC concluded that psyllium seed can be used for the treatment of habitual constipation (constipation not caused by a physical change to an organ) and in conditions where softening of the stools is desirable to reduce pain when they are passed, such as anal fissures, haemorrhoids and after surgery to the anus or rectum.
Slovenian: Odbor HMPC je zaključil, da se lahko seme indijskega trpotca uporablja za zdravljenje habitualne (ponavljajoče) zaprtosti (zaprtost, ki ni posledica organskih sprememb) in pri stanjih, kjer je želeno omehčanje blata za zmanjšanje bolečine pri njegovem odvajanju, na primer pri analnih fisurah (zadnjičnih razpokah), hemoroidih (zlati žili) in po kirurškem posegu na anusu (zadnjiku) ali rektumu (danki).
English: Other information about psyllium seed medicines
Slovenian: Druge informacije o zdravilih, ki vsebujejo seme indijskega trpotca
English: The HMPC recommended that psyllium seed medicines should not be used in patients with a sudden change in bowel habit that continues for more than 2 weeks, and in patients with unexplained bleeding from the rectum and failure to pass stools after using a laxative.
Slovenian: Odbor HMPC je priporočil, da se zdravil, ki vsebujejo seme indijskega trpotca, ne sme uporabljati pri bolnikih z nenadno spremembo pri odvajanju blata, ki traja več kot dva tedna, ter pri bolnikih z nediagnosticirano krvavitvijo iz rektuma (danke) in nezmožnostjo izločanja blata po jemanju odvajal.
English: What evidence supports the use of psyllium seed medicines?
Slovenian: Kateri dokazi podpirajo uporabo zdravil, ki vsebujejo seme indijskega trpotca?
English: Herbal medicines containing psyllium seed are usually available in solid forms to be taken by mouth.
Slovenian: Zdravila rastlinskega izvora, ki vsebujejo seme indijskega trpotca, so navadno na voljo v trdnih oblikah, ki se jemljejo peroralno (zaužijejo skozi usta).
English: How are psyllium seed medicines approved in the EU?
Slovenian: Kako so zdravila, ki vsebujejo seme indijskega trpotca, odobrena v EU?
English: In its assessment, the HMPC considered a number of clinical studies with isphagula seed and ispaghula husk which contains similar ingredients to psyllium seed, showing its effect as a mild laxative.
Slovenian: Odbor HMPC je pri svoji oceni upošteval številne klinične študije s semenom in lupino jajčastega trpotca, ki vsebujejo podobne sestavine kot seme indijskega trpotca ter imajo učinek blagega odvajala.
English: Psyllium seed
Slovenian: Seme indijskega trpotca
English: Psyllium seeds contain dietary fibre which when mixed with water forms a gel-like mass that works as a mild laxative (medicine used to treat constipation).
Slovenian: Semena indijskega trpotca vsebujejo prehranske vlaknine, ki pomešane z vodo tvorijo gelu podobno zmes, ki deluje kot blago odvajalo (zdravilo za zdravljenje zaprtosti).
English: What are the risks associated with psyllium seed medicines?
Slovenian: Kakšna tveganja so povezana z zdravili, ki vsebujejo seme indijskega trpotca?
English: For practical information about using psyllium seed medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o njihovi uporabi naj bolniki preberejo navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujejo z zdravnikom ali farmacevtom.
English: At the same time psyllium seed lubricates the intestine, which improves the transit of stools.
Slovenian: Seme indijskega trpotca obenem podmaže črevo, s čimer se izboljša prehajanje blata.
English: For more information about treatment with psyllium seed medicines, read the package leaflet that comes with the medicine or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravili, ki vsebujejo seme indijskega trpotca, preberite navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujte z zdravnikom ali farmacevtom.
English: Side effects have been reported with psyllium seed medicines, including flatulence and abdominal distension (swelling of the belly).
Slovenian: Pri zdravilih, ki vsebujejo seme indijskega trpotca, so poročali o neželenih učinkih, vključno s flatulenco (nabiranje plinov v želodcu in črevesju, vetrovi) in abdominalno distenzijo (napihnjenostjo trebuha).
English: advice from a doctor or pharmacist should be sought.
Slovenian: Če se zaprtost ne odpravi v treh dneh, se je treba posvetovati z zdravnikom ali farmacevtom.
English: Detailed instruction on how to take psyllium seed medicines and who can use them can be found in the package leaflet that comes with the medicine.
Slovenian: Podrobna navodila o jemanju zdravil, ki vsebujejo seme indijskega
English: Intravenous use vial (glass)
Slovenian: Intravenska uporaba vial (steklo)
English: 50 mg Powder for concentrate for solution for infusion
Slovenian: Prašek za koncentrat za raztopino za infundiranje
English: Date of first authorisation: 23 September 2015
Slovenian: Datum prve odobritve: 23. september 2015.
English: for sevelamer only)
Slovenian: samo za sevelamer)
English: Both studies were performed in North American and/or Asian patients.
Slovenian: Obe študiji so izvedli pri bolnikih iz Severne Amerike in/ali Azije.
English: Do not give this medicine to children and adolescents below the age of 18 years.
Slovenian: To zdravilo se ne sme uporabljati pri otrocih in mladostnikih, mlajših od 18 let.
English: Contact your doctor immediately if you experience:
Slovenian: Nemudoma obvestite svojega zdravnika, če opazite:
English: The safety and efficacy of Fexeric in children and adolescents aged 0 to 18 years have not yet been
Slovenian: Varnost in učinkovitost zdravila Fexeric pri otrocih in mladostnikih, starih od 0 do 18 let, še nista bili
English: All other parameters were secondary or exploratory endpoints in the two studies.
Slovenian: Vsi drugi parametri so bili v teh dveh študijah sekundarni ali eksplorativni opazovani dogodki.
English: Take the next dose at the usual time with a meal.
Slovenian: Naslednji odmerek vzemite ob običajnem času pri obroku.
English: Taking the tablets with meals will help the medicine to work.
Slovenian: Jemanje tablet ob obroku bo pomagalo pri delovanju zdravila.
English: Your doctor will monitor the phosphorus levels regularly.
Slovenian: Zdravnik bo redno spremljal ravni fosforja.
English: Iron overdose is dangerous, particularly in children, and requires immediate attention.
Slovenian: Preveliko odmerjanje železa je nevarno, predvsem pri otrocih, zato je potrebna takojšnja pozornost.
English: Tell your doctor if you wish to breast-feed your baby.
Slovenian: Zdravniku povejte, če želite dojiti svojega otroka.
English: Active Control N=146
Slovenian: Aktivna kontrola N = 146
English: Pain, thirst
Slovenian: bolečina, žeja
English: Non-inferiority to sevelamer carbonate was determined at Week 12.
Slovenian: Neinferiornost sevelamerijevega karbonata so določili v 12. tednu.
English: Tablets should be taken whole.
Slovenian: Tablete je treba zaužiti cele.
English: This can lead to high phosphorus levels in the blood.
Slovenian: To lahko povzroči visoke ravni fosforja v krvi.
English: • Also tell your doctor or pharmacist if you are taking or might take the medicines below.
Slovenian: • Zdravnika ali farmacevta prav tako obvestite, če jemljete ali pa boste morda začeli jemati spodaj navedena zdravila.
English: Effects on phosphorus homeostasis
Slovenian: Učinki na homeostazo fosforja
English: Fexeric increases iron levels in your body.
Slovenian: Zdravilo Fexeric zviša ravni železa v telesu.
English: This blood test may be part of your routine tests for your
Slovenian: Te krvne preiskave so lahko del vaših rednih preiskav
English: The safety and effectiveness of Fexeric have not been studied in this population.
Slovenian: Varnosti in učinkovitosti zdravila Fexeric niso preučevali pri tej skupini bolnikov.
English: Because too much iron is unsafe, your blood will be tested at regular intervals to check iron levels.
Slovenian: Ker je prevelika količina železa nevarna, se bodo redno izvajale krvne preiskave, s katerimi se bodo preverjale ravni železa.
English: Keeping the phosphorus level normal is important to maintain healthy bones and blood vessels and to prevent itchy skin, red eyes, bone pain or bone fractures.
Slovenian: Vzdrževanje normalnih ravni fosforja je pomembno za ohranjanje zdravih kosti in krvnih žil ter preprečevanje srbeče kože, rdečih oči, bolečine v kosteh in kostnih zlomov.
English: Tablets are 19 mm long, 7.2 mm thick and 10 mm wide.
Slovenian: Dolžina tablete je 19 mm, debelina 7,2 mm in širina 10 mm.
English: Your doctor may decrease or increase the starting dose depending on the level of phosphorus in your blood.
Slovenian: Zdravnik lahko zmanjša ali poveča začetni odmerek, kar je odvisno od vaše ravni fosforja v krvi.
English: Fexeric 1 g film-coated tablets
Slovenian: Fexeric 1 g filmsko obložene tablete